Tumor necrosis factor alpha induction of NF-κB requires the novel coactivator SIMPL

Molecular and Cellular Biology

Volumn 24, Issue 21, 2004, Pages 9317-9326

  Kwon, Hyung Joo ^a,c   Breese, Erin Haag ^a   Vig Varga, Eva ^a   Luo, Yong ^a   Lee, Younghee ^a,c   Goebl, Mark G ^a   Harrington, Maureen A ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MS 4071 ^*  (United States)

^c Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEAR PROTEIN; PROTEIN; SIGNALING MOLECULE THAT INTERACTS WITH PELLE LIKE KINASE; SYNAPTOTAGMIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; CARRIER PROTEINS; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE; CELL NUCLEUS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MULTIPROTEIN COMPLEXES; NF-KAPPA B; NUCLEAR LOCALIZATION SIGNALS; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-JUN; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 6344227898     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.21.9317-9326.2004     Document Type: Article

References (30)

1. Baldwin, A. S. 2001. The transcription factor NF-κB and human diseases. J. Clin. Investig. 107:3-6.
2. Chen, Z. J., L. Parent, and T. Maniatis. 1996. Site-specific phosphorylation of IkBa by a novel ubiquitination-dependent protein kinase activity. Cell 84:853-862.
3. DiDonato, J. A., M. Hayakawa, D. M. Rothwarf, E. Zandi, and M. Karin. 1997. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388:548-554.
4. Efthymiadis, A., H. Shao, S. Hubner, and D. A. Jans. 1997. Kinetic characterization of the human retinoblastoma protein bipartite nuclear localization sequence (NLS) in vivo and in vitro. J. Biol. Chem. 272:22134-22139.
5. Fontes, M. R. M., T. The, and B. Kobe. 2000. Structural basis of recognition of monopartite and bipartite nuclear localization sequences by mammalian importin-α. J. Mol. Biol. 297:1183-1194.
6. Hedin, K. E., M. P. Bell, K. R. Kalli, C. J. Huntoon, B. M. Sharp, and D. J. McKean. 1997. Delta-opioid receptors expressed by Jurkat T cells enhance IL-2 secretion by increasing AP-1 complexes and activity of the NF-AT/AP-1-binding promoter element. J. Immunol. 159:5431-5440.
7. Hoffmann, A., T. H. Leung, and D. Baltimore. 2003. Genetic analysis of NF-kB/Rel transcription factors defines functional specificities. EMBO J. 22:5530-5539.
8. Hu, Y., V. Baud, M. Delhase, P. Zhang, T. Deerinck, M. Ellisman, R. Johnson, and M. Karin. 1999. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase. Science 284:316-320.
9. Ito, C. Y., A. G. Kazantsev, and A. S. Baldwin. 1994. Three NF-κB sites in the IκB-α promoter are required for induction of gene expression by TNFα. Nucleic Acids Res. 22:3787-3792.
10. Jans, D. A., C.-Y. Xiao, and M. H. C. Lam. 2000. Nuclear targeting signal recognition: a key control point in nuclear transport? BioEssays 22:532-544.
11. Kalb, A., H. Bluethmann, M. W. Moore, and W. Lesslauer. 1996. Tumor necrosis factor receptors (Tnfr) in mouse fibroblasts deficient in Tnfr1 or Tnfr2 are signaling competent and activate the mitogen-activated protein kinase pathway with differential kinetics. J. Biol. Chem. 271:28097-28104.
12. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:621-663.
13. Le Bail, O., R. Schmidt-Ullrich, and A. Israel. 1993. Promoter analysis of the gene encoding the I kappa B-alpha/MAD3 inhibitor of NF-kappa B: positive regulation by members of the rel/NF-kappa B family. EMBO J. 12:5043-5049.
14. Li, Q., and I. Verma. 2002. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2:725-734.
15. Li, Q., G. Estepa, S. Memet, A. Israel, and I. M. Verma. 2000. Complete lack of NF-kappaB activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation. Genes Dev. 14:1729-1733.
16. Li, Q., Q. Lu, J. Y. Hwang, D. Buscher, K. F. Lee, J. C. Izpisua-Belmonte, and I. M. Verma. 1999. IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev. 13:1322-1328.
17. Li, Q., D. Van Antwerp, F. Mercurio, K. F. Lee, and I. M. Verma. 1999. Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science 284:321-325.
18. Medzhitov, R., and C. Janeway, Jr. 2000. Innate immunity. N. Engl. J. Med. 343:338-344.
19. Mercurio, F., H. Zhu, B. W. Murray, A. Shevchenko, B. L. Bennett, J. W. Li, D. B. Young, M. Barbosa, M. Mann, A. Manning, and A. Rao. 1997. IKK-1 and IKK-2: cytokine-activated IkB kinases essential for NF-kB activation. Science 278:860-866.
20. Regnier, C. H., H. Y. Song, X. Gao, D. V. Goeddel, Z. Cao, and M. Rothe, M. 1997. Identification and characterization of an IkB kinase. Cell 90:373-383.
21. Schnare, M., G. M. Barton, A. C. Holt, K. Takeda, S. Akira, and R. Medzhitov. 2001. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2:947-950.
22. Stein, B., A. S. Baldwin, Jr., B. W. Ballard, W. C. Greene, P. Angel, and P. Herrlich. 1993. Cross-coupling of the NF-κB p65 and Fos/Jun transcription factors produces potential biological function. EMBO J. 12:3879-3891.
23. Stein, B., P. C. Cogswell, Jr., and A. S. Baldwin. 1993. Functional and physical associations between NF-κB and C/EBP family members: Rel domain-b-ZIP interaction. Mol. Cell. Biol. 13:3964-3974.
24. Takeda, K., O. Takeuchi, T Tsujimura, S. Itami, O. Adachi, T. Kawai, H. Sanjo, K. Yoshikawa, N. Terada, and S. Akira. 1999. Limb and skin abnormalities in mice lacking IKKα. Science 284:313-316.
25. Tanaka, M., M. E. Fuentes, K. Yamaguchi, M. H. Durnin, S. A. Dalrymple, K. L. Hardy, and D. V. Goeddel. 1999. Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. Immunity 10:421-429.
26. Turpin, P., B. Ossareh-Nazari, and C. Dargemont. 1999. Nuclear transport and transcriptional regulation. FEBS Lett. 452:82-86.
27. Vig, E., M. Green, Y. Liu, D. B. Donner, N. Mukaida, M. G. Goebl, and M. A. Harrington. 1999. Modulation of tumor necrosis factor and interleukin-1 dependent NF-kB activity by mPLK/IRAK. J. Biol. Chem. 274:13077-13084.
28. Vig, E., M. Green, Y. Liu, K. Kang-Yeol, H.-J. Kwon, J. Tian, M. Goebl, and M. A. Harrington. 2001. SIMPL is a TNF RI-mPLK/IRAK dependent NF-κB activator. J. Biol. Chem. 276:7859-7866.
29. Woronicz, J. B., Z. Gao, Z. Cao, M. Rothe, and D. V. Goeddel. 1997. IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK. Science 278:866-869.
30. Zandi, E., D. M. Rothwarf, M. Delhase, M. Hayakawa, and M. Karin. 1997. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91:243-252.